B-cell diversity in immune system's germinal centers may be key to broad-spectrum vaccines

February 18, 2016, Whitehead Institute for Biomedical Research

When it comes to selecting for B cells that produce antibodies to hostile viruses and bacteria, the immune system hedges its bets. Within the germinal centers that form in the body's lymph nodes during an immune response are B cells that produce antibodies with a range of affinities to an invading pathogen. Darwinian-like cycles of mutation and selection of the fittest lead to an increase in the average affinity across the B cell population.

This new finding from Whitehead Institute scientists overturns a previously held notion that only a handful of B producing the highest affinity antibodies are allowed to survive in the germinal center. Instead, less strict competition allows multiple B cell lineages to evolve simultaneously, whereas winner-take-all events are relatively rare. This revised understanding may aid development of effective vaccines against HIV, influenza, and other viruses that mutate rapidly.

"Our research suggests that we may have a window to rescue B cells that produce antibodies protecting against a family of viruses instead of against one strain," says Whitehead Fellow Gabriel Victora. "These antibodies may initially have lower affinity, so the B cells that produce them need to be preserved before they are outcompeted."

Within the lymph nodes' germinal centers, B cells are presented with antigens—pieces of an invading virus or cell. In response, the B cells produce antibodies that attach firmly to these antigens. Invaders tagged with antibodies are identified as foreign and destroyed by phagocytes or neutralized by other aspects of the . The higher the antibodies' affinity for an interloper's antigens, the more likely the immune system will be able to defeat the infection.

To produce these high-quality antibodies, B cells undergo a selection process in the germinal centers. B cells mutate their antibody genes randomly, yielding a population of descendants with a range of different affinities. Those producing less effective antibodies are edged out by B cells whose antibodies "stick" better to the invader. Researchers had thought that this evolution in miniature would likely continue until only the few B cells creating the fittest antibodies survive.

But a team led by Victora lab scientists Jeroen Tas and Luka Mesin saw something different. After they used fluorescent proteins to permanently tag individual B cells and their progeny, they watched as the B cells underwent selection. While the predicted jackpot events were indeed observed in some germinal centers, most germinal centers contained a variety of B cells, so that, in the same response, germinal centers spanned the full spectrum of heterogeneity, from those with complete domination by the progeny of one B cell, to some with a moderate variety of B cells, to others with a wide array of B cells. The team's work is described this week online in the journal Science.

"There is a benefit to preserving diversity," says Mesin, a postdoctoral researcher. "It makes sense that, while the cells that are the 'best' for the ongoing response are selected, also those with the potential to be the 'best' for future responses to related pathogens are maintained. This is the essence of evolution, and it's happening every day in our bodies."

For scientists working to improve vaccines for HIV or to create vaccines with broad protection for numerous strains of influenza, the insight into germinal center B cell diversity could be immensely helpful.

"These viruses mutate frequently, yet certain conserved regions of them are difficult to change," says Tas, who is a former graduate student in the Victora lab and currently at Harvard Medical School. "If those parts do change, often the viruses are unable to function. However, many antibodies targeting these stable regions appear to start out with lower affinity, and are thought to be mostly lost due to competition. By increasing our understanding of how germinal centers function we might be able to encourage the immune system to actively mutate these antibodies, eventually generating broadly neutralizing for these viruses."

Explore further: Cell division speeds up as part of antibody selection, study shows

More information: Visualizing Antibody Affinity Maturation in Germinal Centers, DOI: 10.1126/science.aad3439

Related Stories

Cell division speeds up as part of antibody selection, study shows

July 16, 2015
It's a basic principle of immunology: When a germ invades, the body adapts to that particular target and destroys it. But much remains unknown about how the immune system refines its defensive proteins, called antibodies, ...

Discovery helps explain how B cells adapt to their targets

May 7, 2014
(Medical Xpress)—Over the weeks following an invasion by a disease-causing microbe, the human immune system fine tunes its defenses, producing proteins called antibodies that are ever more precisely targeted at the invader. ...

Imaging studies open a window on how effective antibodies are formed

September 24, 2014
Sometimes, in order to understand what's happening in the immune system, you just have to watch it. By imaging the immune response, researchers have observed how two types of immune cells, T and B cells, interact with one ...

A trigger that likely unleashes autoimmune disease

May 12, 2015
Australian researchers believe they have discovered a group of cells that trigger autoimmune disease, as well as the molecular 'trigger guard' that normally holds them in check.

Imaging studies reveal how high-affinity antibodies are selectively generated by immunization

October 16, 2014
Circulating antibodies play a crucial role in host defense against microbial infections, and antibody-based vaccines remain the best hope for preventing infections by deadly viruses such as HIV and Ebola. To combat viruses, ...

Recommended for you

Improving vaccines for the elderly by blocking inflammation

January 22, 2018
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.